drug · small molecule
patient view →camlipixant
Phase 3updated 2mo agoby $GSK GSK plc🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Phase 3 (across all indications), with 2 investigational indications.
targets
P2X purinoceptor 3
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that